UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
Notable Analyst Rating Changes 06/15: (NTAP) (ARUN) (FIG) Upgraded; (CPST) (MYGN) (SOL) Downgraded
-
Notable Analyst Rating Changes 06/02: (AFFX) (JNJ) (DV) Upgraded; (GIS) (ES) (SRE) Downgraded
-
UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Chock-full
-
UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Updating Model with Zytiga
-
Notable 52-Week Highs and Lows of the Day 05/12: (SYMC) (QCOR) (TJX) High; (CLWR) (PNSN) (HEV) Low
-
Notable Analyst Rating Changes 05/11: (JNJ) (NTAP) (SYK) Upgraded; (RIMM) (HSP) (SPWRA) Downgraded
-
UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Zytiga (abiraterone) Approved
-
UBS Still Likes Perrigo Co. (PRGO); Raising Estimates & Price Target
-
Notable Mergers and Acquisitions of the Day 10/06: GE, RBN/TTES, HBE/KTOS, JNJ/CRXL
-
UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); 2Q10: MD&D Disappoints
-
Boson Scientific (BSX) Earnings Preview: Shares Fibrillated Through Q1, Look to Restore Rhythm (STJ, MDT, JNJ)
-
UBS Maintains a 'Buy' Rating on Boston Scientific (BSX); Adjusts Estimates & PT
-
Trading Radar for 01/26: Yahoo! (YHOO), W.W. Grainger (GWW), A.O. Smith (AOS), Delta Air Lines (DAL), Sherwin-Williams (SHW) Report
-
Johnson & Johnson (JNJ) Subsidiary Centocor Bio Announces Positive Phase III Simponi Results
-
Trading Radar for 10/13: Johnson and Johnson (JNJ), CSX Corp. (CSX), Intel (INTC), Domino's Pizza (DPZ), KMG Chemical (KMGB), Altera (ALTR), Bank of the Ozarks (OZRK) Report
-
Barron's Article Makes Comments on Steris (STE); Sees Potential For Continued Growth With Flu Season Upon Us
-
Notable Analyst Rating Changes 8/13: HD, CCE, WX, TXN Upgraded; LOW, NOK, SOL, JASO, PALM, XTO Downgraded
-
David Moenning's Daily State of the Markets: 7/14
-
Notable Mergers and Acquisitions of the Day 7/2: JNJ/ELN, FCSX/IAAC, LSTR
-
Morning Movers 7/2: ELN, QUIK, ESLR Higher; DSCO, LEA, SEPR, ILMN, MANH Lower
-
Johnson & Johnson (JNJ) To Acquire Alzheimer's Assets From Elan (ELN), Invests $1B For 18.4% Stake
-
Johnson & Johnson's (JNJ) Wins $1.67B Patent Verdict Versus Abbott Laboratories (ABT)
-
David Moenning's Daily State of the Markets: 4/20
-
Morning Movers 4/14: DNDN, DBRN, AIG, MGM, FSS, LVS Higher; TLB, SXL, MS, VCLK, OESX, PTRY Lower
-
Notable Analyst Rating Changes 3/20: MRK, JAS, JNJ Upgraded; JCG, URBN, AN Downgraded
-
Morning Movers: Xerox (XRX) Lower On Profit Warning, Dry Bulk Shippers Lower On Downgrade (ESEA, EGLE, DSX)
-
David Moenning's Daily State of the Markets: 3/20
-
UBS Upgrades Johnson & Johnson (JNJ) to Buy
-
David Moenning's Daily State of the Markets: 1/20
-
David Moenning's Daily State of the Markets: 10/29
-
Notable Analyst Rating Changes 10/29: BIIB, MTH, PCU Upgraded; JNJ, SWIR, ULTI Downgraded
-
David Moenning's Daily State of the Markets: 10/14
-
Notable Analyst Rating Changes 9/5: UL, MON, NAV, HOS Upgraded; ANF, TJX, AMD, NBR Downgraded
-
Notable Analyst Rating Changes 8/15: SPWR, PCLN, ADSK Upgraded; JNJ, JWN, DNA Downgraded
-
David Moenning's Daily State of the Markets: 7/15
-
David Moenning's Daily State of the Markets: 1/22
-
Notable Analyst Rating Changes 1/04: DISH, PTR, JTX Upgraded; INTC, DO, HES Downgraded
-
UBS Initiates Coverage on Johnson & Johnson (JNJ) with a Buy
